Clinical, Metabolic Factors Influence T2D Remission After Gastric Bypass
THURSDAY, July 6, 2023 -- Regardless of weight loss, a significant proportion of patients experience type 2 diabetes (T2D) remission after Roux-en-Y gastric bypass (RYGB), according to a study presented at the annual meeting of the American Society...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Gastric Bypass | Gastroenterology | Pharmaceuticals | Study | Weight Loss